The fibrinopeptide lβ15-42 reduces inflammation in mice subjected to polymicrobial sepsis

Shock

Volumn 38, Issue 3, 2012, Pages 275-280

  Jennewein, Carla ^a   Mehring, Martina ^a   Tran, Nguyen ^a   Paulus, Patrick ^a   Ockelmann, Pia Alexandra ^a   Habeck, Katharina ^a   Latsch, Kathrina ^a   Scheller, Bertram ^a   Zacharowski, Kai ^a   Mutlak, Haitham ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Fibrinopeptides; inflammation; sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; FIBRINOPEPTIDE B; FIBRINOPEPTIDE BBETA [15-42]; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; ANTIINFLAMMATORY AGENT; FIBRIN DEGRADATION PRODUCT; FIBRINOPEPTIDE BBETA (15 42); FIBRINOPEPTIDE BBETA (15-42); PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CECUM DISEASE; CELL JUNCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; LIVER; LIVER INJURY; LOADING DRUG DOSE; LUNG; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSMOTIC PUMP; RANDOMIZED CONTROLLED TRIAL; SEPSIS; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; NEUTROPHIL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS;

EID: 84865500714     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318264b95d     Document Type: Article

References (21)

1. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, et al.: Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33(4):606-618, 2007. (Pubitemid 46474888)
2. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, Burchardi H: A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care 11(3):R69, 2007.
3. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, Gastmeier P, Gerlach H, Grundling M, John S, et al.: Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI) (German). Anaesthesist 59(4):347-370, 2010.
4. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138-150, 2003. (Pubitemid 36056721)
5. Russell JA: Management of sepsis. N Engl J Med 355(16):1699-1713, 2006. (Pubitemid 44583960)
6. London NR, Zhu W, Bozza FA, Smith MC, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, et al.: Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2(23):23ra19, 2010.
7. Levi M: The coagulant response in sepsis and inflammation. Hamostaseologie 30(1):10-12, 14-16, 2010.
8. Jennewein C, Tran N, Paulus P, Ellinghaus P, Eble JA, Zacharowski K: Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 17(5-6):568-573, 2011.
9. Levi M, van der Poll T, Buller HR: Bidirectional relation between inflammation and coagulation. Circulation 109(22):2698-2704, 2004. (Pubitemid 38737913)
10. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, Castellino FJ, Groger M, Wolff K, Zacharowski K: The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11(3):298-304, 2005. (Pubitemid 40460558)
11. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Suselbeck T, et al.: Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53(8): 720-729, 2009.
12. Gröger M, Pasteiner W, Ignatyev G, Matt U, Knapp S, Atrasheuskaya A, Bukin E, Friedl P, Zinkl D, Hofer-Warbinek R, et al.: Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 4(4):e5391, 2009.
13. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99(6):683-690, 1992. (Pubitemid 23002027)
14. Weigert A, Johann AM, von Knethen A, Schmidt H, Geisslinger G, Brune B: Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 108(5):1635-1642, 2006. (Pubitemid 44316132)
15. Roesner JP, Petzelbauer P, Koch A, Tran N, Iber T, Vagts DA, Scheeren TW, Vollmar B, Noldge-Schomburg GE, Zacharowski K: Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion. Crit Care Med 37(2):598-605, 2009.
16. Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossmann H, Vestweber D: VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 110(Pt 5):583-588, 1997. (Pubitemid 27153972)
17. Sharma VK, Dellinger RP. Treatment options for severe sepsis and septic shock. Expert Rev Anti Infect Ther 4(3):395-403, 2006. (Pubitemid 43905462)
18. Skrupky LP, Kerby PW, Hotchkiss RS. Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology 115(6): 1349-1362, 2011.
19. Webster NR, Galley HF: Immunomodulation in the critically ill. Br J Anaesth 103(1):70-81, 2009.
20. Schmidt MV, Paulus P, Kuhn AM, Weigert A, Morbitzer V, Zacharowski K, Kempf VA, Brune B, von Knethen A: Peroxisome proliferator-activated receptor gamma-induced T cell apoptosis reduces survival during polymicrobial sepsis. Am J Respir Crit Care Med 184(1):64-74, 2011.
21. Lee WL, Slutsky AS: Sepsis and endothelial permeability. N Engl J Med 363(7):689-691, 2010.